title: Animal models for Ebola and Marburg virus infections.
abstract: Ebola and Marburg hemorrhagic fevers (EHF and MHF) are caused by the Filoviridae family, Ebolavirus and Marburgvirus (ebolavirus and marburgvirus), respectively. These severe diseases have high mortality rates in humans. Although EHF and MHF are endemic to sub-Saharan Africa. A novel filovirus, Lloviu virus, which is genetically distinct from ebolavirus and marburgvirus, was recently discovered in Spain where filoviral hemorrhagic fever had never been reported. The virulence of this virus has not been determined. Ebolavirus and marburgvirus are classified as biosafety level-4 (BSL-4) pathogens and Category A agents, for which the US government requires preparedness in case of bioterrorism. Therefore, preventive measures against these viral hemorrhagic fevers should be prepared, not only in disease-endemic regions, but also in disease-free countries. Diagnostics, vaccines, and therapeutics need to be developed, and therefore the establishment of animal models for EHF and MHF is invaluable. Several animal models have been developed for EHF and MHF using non-human primates (NHPs) and rodents, which are crucial to understand pathophysiology and to develop diagnostics, vaccines, and therapeutics. Rhesus and cynomolgus macaques are representative models of filovirus infection as they exhibit remarkably similar symptoms to those observed in humans. However, the NHP models have practical and ethical problems that limit their experimental use. Furthermore, there are no inbred and genetically manipulated strains of NHP. Rodent models such as mouse, guinea pig, and hamster, have also been developed. However, these rodent models require adaptation of the virus to produce lethal disease and do not mirror all symptoms of human filovirus infection. This review article provides an outline of the clinical features of EHF and MHF in animals, including humans, and discusses how the animal models have been developed to study pathophysiology, vaccines, and therapeutics.
authors.affiliation: Department of Virology 1, National Institute of Infectious Diseases Tokyo, Japan.
authors.forename: Eri
authors.initials: E
authors.lastname: Nakayama
authors.forename: Masayuki
authors.initials: M
authors.lastname: Saijo
keywords: Ebola virus; Marburg virus; animal models; filovirus; viral hemorrhagic fever
references.citation: J Infect Dis. 2011 Nov;204 Suppl 3:S1011-20
references.pmid: 21987737
references.citation: Vaccine. 2010 Jan 22;28(4):950-7
references.pmid: 19925902
references.citation: Nature. 2003 Aug 7;424(6949):681-4
references.pmid: 12904795
references.citation: J Virol. 2007 Dec;81(24):13469-77
references.pmid: 17928350
references.citation: Antimicrob Agents Chemother. 2009 May;53(5):2089-99
references.pmid: 19223614
references.citation: PLoS One. 2009;4(5):e5547
references.pmid: 19440245
references.citation: Lancet. 1995 Dec 23-30;346(8991-8992):1669-71
references.pmid: 8551825
references.citation: Expert Rev Vaccines. 2008 May;7(4):417-29
references.pmid: 18444889
references.citation: J Infect Dis. 2011 Nov;204 Suppl 3:S953-6
references.pmid: 21987775
references.citation: Int J Exp Pathol. 1995 Aug;76(4):227-36
references.pmid: 7547435
references.citation: Plant Biotechnol J. 2011 Sep;9(7):807-16
references.pmid: 21281425
references.citation: Arch Virol Suppl. 2008;20:13-360
references.pmid: 18637412
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S199-202
references.pmid: 9988185
references.citation: J Gen Virol. 2001 Jun;82(Pt 6):1365-1373
references.pmid: 11369881
references.citation: Virology. 1998 Nov 10;251(1):28-37
references.pmid: 9813200
references.citation: J Virol. 2006 Mar;80(5):2267-79
references.pmid: 16474134
references.citation: J Virol. 2007 May;81(9):4654-63
references.pmid: 17329340
references.citation: Thromb Res. 2000 Feb 1;97(3):153-62
references.pmid: 10680646
references.citation: J Virol. 2011 May;85(9):4222-33
references.pmid: 21325402
references.citation: Vaccine. 2011 Apr 5;29(16):2968-77
references.pmid: 21329775
references.citation: J Biotechnol. 1996 Jan 26;44(1-3):111-8
references.pmid: 8717394
references.citation: J Clin Microbiol. 2001 Nov;39(11):4125-30
references.pmid: 11682540
references.citation: J Pathol. 1978 Jul;125(3):131-8
references.pmid: 102747
references.citation: Nature. 2000 Nov 30;408(6812):605-9
references.pmid: 11117750
references.citation: PLoS Negl Trop Dis. 2011 Aug;5(8):e1275
references.pmid: 21858240
references.citation: J Immunol Methods. 2011 May 31;368(1-2):24-35
references.pmid: 21334343
references.citation: PLoS Pathog. 2011 Oct;7(10):e1002304
references.pmid: 22039362
references.citation: Br J Exp Pathol. 1978 Dec;59(6):584-93
references.pmid: 106868
references.citation: J Infect Dis. 2013 Jan 15;207(2):306-18
references.pmid: 23045629
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S1-7
references.pmid: 9988155
references.citation: Nature. 2011 Aug 24;477(7364):344-8
references.pmid: 21866101
references.citation: J Virol. 2003 Aug;77(15):8263-71
references.pmid: 12857895
references.citation: PLoS Pathog. 2007 Jan;3(1):e2
references.pmid: 17238284
references.citation: Lab Anim Sci. 1992 Apr;42(2):152-7
references.pmid: 1318446
references.citation: Viruses. 2012 Sep;4(9):1477-508
references.pmid: 23170168
references.citation: Arch Pathol Lab Med. 1996 Feb;120(2):140-55
references.pmid: 8712894
references.citation: Virology. 2009 Jan 20;383(2):348-61
references.pmid: 19010509
references.citation: Microb Pathog. 1990 Oct;9(4):219-26
references.pmid: 1965845
references.citation: Viruses. 2011 Sep;3(9):1634-49
references.pmid: 21994800
references.citation: J Virol. 2009 Apr;83(8):3810-5
references.pmid: 19211761
references.citation: J Virol. 2006 Mar;80(6):2738-46
references.pmid: 16501083
references.citation: Arch Virol Suppl. 1996;11:115-34
references.pmid: 8800793
references.citation: Vaccine. 2000 Aug 15;19(1):142-53
references.pmid: 10924796
references.citation: Science. 2004 Jan 16;303(5656):387-90
references.pmid: 14726594
references.citation: J Gen Virol. 2005 Apr;86(Pt 4):1181-1188
references.pmid: 15784912
references.citation: J Virol. 2010 Jan;84(2):1169-75
references.pmid: 19889762
references.citation: Arch Virol Suppl. 1996;11:101-14
references.pmid: 8800792
references.citation: BMJ. 2009 Mar 23;338:b1223
references.pmid: 19307268
references.citation: Virology. 2006 Sep 30;353(2):324-32
references.pmid: 16820184
references.citation: Antiviral Res. 2010 Aug;87(2):187-94
references.pmid: 20452380
references.citation: J Virol. 2004 Oct;78(19):10370-7
references.pmid: 15367603
references.citation: Biosecur Bioterror. 2011 Dec;9(4):361-71
references.pmid: 22070137
references.citation: J Pathol. 1985 Nov;147(3):199-209
references.pmid: 4067737
references.citation: Clin Exp Immunol. 2002 Apr;128(1):163-8
references.pmid: 11982604
references.citation: Rev Med Virol. 2010 Nov;20(6):344-57
references.pmid: 20658513
references.citation: Virology. 2000 Nov 10;277(1):147-55
references.pmid: 11062045
references.citation: J Virol. 2009 Jul;83(14):7296-304
references.pmid: 19386702
references.citation: Lab Invest. 1971 Apr;24(4):279-91
references.pmid: 4997371
references.citation: J Virol. 2009 Jul;83(13):6404-15
references.pmid: 19369350
references.citation: Vector Borne Zoonotic Dis. 2009 Dec;9(6):723-8
references.pmid: 19323614
references.citation: PLoS Pathog. 2012 Feb;8(2):e1002550
references.pmid: 22383882
references.citation: J Infect Dis. 2011 Jan 15;203(2):175-9
references.pmid: 21288816
references.citation: Curr Top Microbiol Immunol. 1999;235:97-116
references.pmid: 9893381
references.citation: J Infect Dis. 1985 Nov;152(5):887-94
references.pmid: 4045253
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S248-58
references.pmid: 9988191
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S177-87
references.pmid: 9988182
references.citation: Emerg Infect Dis. 2002 May;8(5):503-7
references.pmid: 11996686
references.citation: Vaccine. 2003 Sep 8;21(25-26):4071-80
references.pmid: 12922144
references.citation: Nat Med. 1999 Apr;5(4):423-6
references.pmid: 10202932
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S115-9
references.pmid: 9988174
references.citation: Virus Res. 2010 Oct;153(1):121-33
references.pmid: 20654661
references.citation: PLoS Pathog. 2006 Jul;2(7):e73
references.pmid: 16848640
references.citation: J Immunol. 2005 Apr 1;174(7):4198-202
references.pmid: 15778381
references.citation: J Virol. 2010 Oct;84(19):10386-94
references.pmid: 20660192
references.citation: Virology. 1998 Jun 20;246(1):134-44
references.pmid: 9657001
references.citation: PLoS Pathog. 2006 Jan;2(1):e1
references.pmid: 16415982
references.citation: J Infect Dis. 2007 Nov 15;196 Suppl 2:S390-9
references.pmid: 17940975
references.citation: J Infect Dis. 2007 Nov 15;196 Suppl 2:S372-81
references.pmid: 17940973
references.citation: Vet Pathol. 2010 Sep;47(5):831-51
references.pmid: 20807825
references.citation: Expert Rev Vaccines. 2011 Jan;10(1):63-77
references.pmid: 21162622
references.citation: J Virol. 2008 Jun;82(11):5664-8
references.pmid: 18385248
references.citation: Nat Med. 2010 Sep;16(9):991-4
references.pmid: 20729866
references.citation: Lancet. 2003 Dec 13;362(9400):1953-8
references.pmid: 14683653
references.citation: J Virol. 2007 Jun;81(12):6379-88
references.pmid: 17428868
references.citation: J Clin Invest. 1997 Jan 15;99(2):209-19
references.pmid: 9005989
references.citation: J Infect Dis. 2011 Nov;204 Suppl 3:S1021-31
references.pmid: 21987738
references.citation: Exp Anim. 2002 Apr;51(2):173-9
references.pmid: 12012728
references.citation: Lancet. 1977 Mar 12;1(8011):571-3
references.pmid: 65662
references.citation: Biull Eksp Biol Med. 1995 Sep;120(9):302-4
references.pmid: 8593345
references.citation: Lab Invest. 2000 Feb;80(2):171-86
references.pmid: 10701687
references.citation: Arch Virol. 2013 Jan;158(1):301-11
references.pmid: 23001720
references.citation: Vopr Virusol. 1991 Sep-Oct;36(5):435-7
references.pmid: 1803784
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S8-10
references.pmid: 9988156
references.citation: J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7
references.pmid: 17940980
references.citation: Clin Vaccine Immunol. 2008 Mar;15(3):460-7
references.pmid: 18216185
references.citation: Am J Trop Med Hyg. 1996 Jul;55(1):81-8
references.pmid: 8702027
references.citation: Lancet. 2010 May 29;375(9729):1896-905
references.pmid: 20511019
references.citation: J Med Virol. 1980;6(2):129-38
references.pmid: 6165800
references.citation: J Infect Dis. 2006 Jun 15;193(12):1650-7
references.pmid: 16703508
references.citation: Vopr Virusol. 1992 May-Jun;37(3):156-7
references.pmid: 1441443
references.citation: J Infect Dis. 2007 Nov 15;196 Suppl 2:S421-9
references.pmid: 17940979
references.citation: Am J Pathol. 2003 Dec;163(6):2371-82
references.pmid: 14633609
references.citation: Trans R Soc Trop Med Hyg. 1969;63(3):303-9
references.pmid: 4978540
references.citation: J Comp Pathol. 2001 Nov;125(4):243-53
references.pmid: 11798241
references.citation: Lancet. 2006 Apr 29;367(9520):1399-404
references.pmid: 16650649
references.citation: J Med Virol. 1979;4(3):239-40
references.pmid: 536744
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15889-94
references.pmid: 14673108
references.citation: J Infect Dis. 2011 Nov;204 Suppl 3:S991-9
references.pmid: 21987781
references.citation: Infect Immun. 1982 Aug;37(2):771-8
references.pmid: 6749685
references.citation: J Virol. 2006 Oct;80(19):9659-66
references.pmid: 16973570
references.citation: Arch Pathol Lab Med. 1997 Aug;121(8):805-19
references.pmid: 9278608
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94
references.pmid: 11027311
references.citation: Am J Pathol. 2003 Dec;163(6):2347-70
references.pmid: 14633608
references.citation: Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20661-6
references.pmid: 23185024
references.citation: Lancet. 1990 Mar 3;335(8688):502-5
references.pmid: 1968529
references.citation: J Virol. 2004 Apr;78(8):4330-41
references.pmid: 15047846
references.citation: J Infect Dis. 2007 Nov 15;196 Suppl 2:S296-304
references.pmid: 17940964
references.citation: Viruses. 2012 Dec 14;4(12):3754-84
references.pmid: 23242370
references.citation: Virology. 2009 Jan 5;383(1):12-21
references.pmid: 18986663
references.citation: Clin Vaccine Immunol. 2006 Nov;13(11):1267-77
references.pmid: 16988008
references.citation: Dis Model Mech. 2009 Jan-Feb;2(1-2):12-7
references.pmid: 19132113
references.citation: Br J Exp Pathol. 1968 Oct;49(5):458-64
references.pmid: 5727750
references.citation: Viruses. 2012 Sep;4(9):1619-50
references.pmid: 23170176
references.citation: Vopr Virusol. 1991 Nov-Dec;36(6):506-8
references.pmid: 1785188
references.citation: Antiviral Res. 2009 Sep;83(3):245-51
references.pmid: 19523489
references.citation: J Infect Dis. 2003 Dec 1;188(11):1618-29
references.pmid: 14639531
references.citation: Emerg Infect Dis. 2010 Jul;16(7):1119-22
references.pmid: 20587184
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S203-17
references.pmid: 9988186
references.citation: Pediatrics. 1998 Jun;101(6):1013-9
references.pmid: 9606228
references.citation: Virology. 2010 Apr 10;399(2):290-8
references.pmid: 20129638
references.citation: Nat Med. 2005 Jul;11(7):786-90
references.pmid: 15937495
references.citation: J Infect Dis. 2011 Nov;204 Suppl 3:S1090-7
references.pmid: 21987746
references.citation: J Infect Dis. 1992 Oct;166(4):753-63
references.pmid: 1527410
references.citation: Nat Med. 1998 Jan;4(1):37-42
references.pmid: 9427604
references.citation: Vopr Virusol. 1995 Nov-Dec;40(6):257-60
references.pmid: 8686261
references.citation: Immunol Lett. 2000 Feb 1;71(2):131-40
references.pmid: 10714441
references.citation: Vopr Virusol. 1991 Sep-Oct;36(5):421-3
references.pmid: 1803779
references.citation: Trans R Soc Trop Med Hyg. 1978;72(2):188-91
references.pmid: 418537
references.citation: Vopr Virusol. 1994 Mar-Apr;39(2):82-4
references.pmid: 8017061
references.citation: Arch Virol. 1996;141(5):909-21
references.pmid: 8678836